Left atrial appendage occluder

Interventional device for percutaneous closure of atrial septal defects in pediatric and adult patients. Offers minimally invasive alternative to surgical repair for congenital heart conditions.

Percutaneous closure device for patent foramen ovale treatment in congenital heart disease, with clinical follow-up data documenting safety and efficacy.

An implantable device designed to close the left atrial appendage, reducing stroke risk in patients with atrial fibrillation who cannot tolerate anticoagulation.

An occluder device designed for the closure of patent ductus arteriosus (PDA) in cardiac patients. It is part of the Occlunix® occluders and delivery systems product line.

Occluder devices designed for minimally invasive transcatheter closure of congenital heart defects, including atrial septal defects and patent foramen ovale. Manufactured using biocompatible animal-derived materials with chemical modification technology to reduce nickel ion leaching. Enables effective structural repair while avoiding open-heart surgery in pediatric and adult patients.

Braiding machinery for producing medical occluders used in interventional cardiology and closure procedures. Generates precise braided structures for septal defect and vascular closure devices.

Minimally invasive intervention device for structural heart disease treatment including atrial septal defect and left atrial appendage closure applications.

Interventional implant for treating structural cardiac defects such as atrial septal defects or patent foramen ovale. Provides percutaneous closure without open surgery.

An interventional Class III medical device designed for clinical cardiovascular emergency care. The device is inserted through the femoral artery, with an inlet tube placed in the left ventricle and outlet positioned in the aorta, connected by artificial blood vessels. During operation, it actively reduces left ventricular load and significantly improves perfusion to major organs including the heart, brain, and kidneys. It is applicable to acute decompensated heart failure with cardiogenic shock, intraoperative circulatory support for high-risk PCI procedures, end-stage heart failure acute decompensation, and cardiac arrest from severe trauma.

A Class III interventional medical device for acute and critical cardiovascular disease. The device is inserted via the femoral artery, with the pump inlet placed in the left ventricle and outlet in the aorta, connected by an artificial blood vessel. During operation, it pumps blood from the left ventricle into the aorta, reducing left ventricular load and improving perfusion to vital organs. It is applicable to acute myocardial infarction with cardiogenic shock, intra-operative circulatory support for high-risk PCI procedures, acute decompensation of end-stage heart failure, and cardiac arrest from severe trauma.

Specialized surface coating providing long-lasting antithrombogenic and fibrin sheath protection for implantable and vascular medical devices to reduce thrombosis complications.

Specialized introducer sheath for aortic endovascular interventions, designed to minimize bleeding and optimize device delivery during complex aortic procedures.